Latvia vs Singapore: Proportion of bloodstream infection due to Escherichia coli resistant
Latvia
22.9%
in 2023
Singapore
23.8%
in 2023
Latvia rank
37th
Singapore rank
36th
Proportion of bloodstream infection due to Escherichia coli resistant over time
- Latvia
- Singapore
How they compare
Singapore currently reports 23.8% against 22.9% in Latvia, a difference of 0.9%.
The two have swapped places 2 times across 5 shared years of data; in 2019 it was Singapore ahead.
Latvia ranks 37th and Singapore ranks 36th of 58 countries.
Singapore has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 18.1% | 28.7% | 10.6% | Singapore |
| 2020s | 22.8% | 26.4% | 3.6% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to escherichia coli resistant, Latvia or Singapore?
- Singapore, at 23.8% against 22.9% in Latvia as of 2023.
- What is the difference in proportion of bloodstream infection due to escherichia coli resistant between Latvia and Singapore?
- 0.9%, with Singapore ahead.
- How many years of comparable data are there for Latvia and Singapore?
- 5 years are reported by both, from 2019 to 2023.
- How do Latvia and Singapore rank globally for proportion of bloodstream infection due to escherichia coli resistant?
- Latvia ranks 37th and Singapore ranks 36th of 58 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to Escherichia coli resistant to third-generation cephalosporins (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.